Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-301-3 | CAS number: 13732-62-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro
An Ames test was conducted with morpholinium toluene-4-sulphonate according to OCED 471 (BASF SE, 2013). Negative results were found in all tested strains (TA 1535, TA 1537, TA 98, TA 100, and E.coli WP2) for the applied concentrations of 0, 33, 100, 333, 1000, 3500, and 7000 µg/plate with and without metabolic activation.
In addition, several studies are available for morpholine and p-toluenesulphonic acid.
Morpholine was evaluated for its mutagenic potential in a mouse lymphoma forward mutation assay equivalent to OECD 476 (Huntsman, 1979). Here, L5178Y TK +/- cells were used and concentrations up to 1.25 µL/mL in the presence and absence of metabolic activation (S9 mix) were tested. The assay was repeated; in a third assay concentrations ranging from 1.2 to 2 µL/mL were also tested. The positive controls induced the appropriate responses. The test material induced small increases in the mutation frequency over the applied concentration range of 0.625 to 1.25 µL/mL without metabolic activation. These treatments were highly toxic and the mutant frequency increases (approximately 2.5 -fold) were at the limit of detectability for this assay with microsomal activation; concentrations up to 1.0 - 1.25 µL/mL were not very toxic and not detectably mutagenic. Concentrations from 1.2 - 1.5 µl/mL were excessively lethal. Under the conditions of this study, Morpholine was considered to be very weakly mutagenic in the assay without metabolic activation.
In a sister chromatid exchange assay performed similar to OECD 479, Chinese hamster ovary cells (CHO cells) were treated with morpholine at concentrations of 3.13, 6.25, 12.50, 25.00, 50.00 or 100.00 nL/mL in the presence and absence of mammalian metabolic activation (S9 mix) (Huntsman, 1980). Positive control items induced the appropriate responses. The maximum increases in sister chromatid exchange noted were only 25 % and 22 % with and without S9 mix, respectively. Morpholine did not cause a meaningful increase in sister chromatid exchange under the conditions of this assay.
Furthermore, a mammalian chromosome aberration test forp-toluenesulphonic acid is available, performed according to OECD 473 under GLP. Here, Chinese hamster lung fibroblasts (V79) were treated with and without metabolic activation with concentrations up to 1902 µg/mL(Habrinol, 1988).No significant reproducible enhancement of the chromosome aberration rate compared to the solvent control was found with any of the concentrations used, neither with, nor without metabolic activation by S9-mix.
In vivo
No studies are available for morpholinium toluene-4-sulphonate.
In atransplacental mutagenesis study, sodium nitrite combined with Morpholine or Morpholine alone (500 mg/kg bw) were administered by single oral gavage to pregnant Syrian golden hamsters on day 11 or 12 of pregnancy (Inui et al., 1979). Twenty-four hours after treatment, the hamster embryos were excised and examined for chromosomal aberrations, micronucleus formation, morphological or malignant transformation and drug resistance mutation. Cells exposed in utero to Morpholine showed no increases in the numbers of chromosomal aberrations, micronuclei, 8 -azaguanine- or ouabain-resistant mutants, or transformation rates. The number of resistant colonies was markedly increased after administration of sodium nitrite together with Morpholine only, showing that Morpholine alone has no mutagenic effect in vivo under the conditions of this study. In this in vivo study there was no evidence for mutagenic effects of Morpholine over background.
Endpoint Conclusion:
Justification for classification or non-classification
Based on the results of reliable studies obtained in vitro and in vivo for the source chemicals morpholinium toluene-4 -sulphonate, morpholine, and p-toluenesulphonic acid, the target chemical morpholinium toluene-4 -sulphonate is not considered to be subject to classification for genetic toxicity according to Directive 67/548/EEC (DSD) and Regulation (EC) No 1272/2008 (GHS/CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.